NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: POSSIBILITIES OF REDUCING BACK PAIN INTENSITY IN PATIENTS WITHOSTEOPOROSIS

Objective: to evaluate the efficiency and tolerability of a 10-day course of therapy with different doses of meloxicam in patients with osteoporosis and back pain. Subjects and methods. The study covered 60 women (mean age 70±7 years), who were randomized to 3 groups: those who received meloxicam in doses of 15 and 7,5 mg and controls. Results. During 10-day therapy, there was a significant reduction in the intensity of back pain when meloxicam was given in doses of both 7,5 mg and 15 mg/day (p < 0,001) as compared with the baseline level and in the control group (p < 0,05). At the same time, the pain syndrome became insignificantly lower in the control group following 10 days (p > 0,05). In the first 2 groups, movement restriction significantly reduced, as well as physical activity increased and health improved, as rated by the Oswestry and EQ-5D questionnaires. Improvement was recorded in 27 (67,5%) patients, a satisfactory effect was seen in 10 (25%), there was no effect in 3 (7,5%) women. Conclusion. The treatment was generally well tolerated.

Abstract licence: CC BY

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.